CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

You are here

Products

back to search results

PSA (Prostate Specific Antigen) [A67-B/E3]

Product group: Primary
Monoclonal/ Polyclonal: Monoclonal
Clone: A67-B/E3
Host: Mouse
Isotype: IgG1
Application: Flow cytometry (FC), Immunofluorescence (IF), Immunohistochemistry (IHC)
Application notes: Prediluted
Conjugation Type: Unconjugated
Lightchain type: Kappa
Reactivity: Human
General notes: Localization: cytoplasm.
Buffer: citrate pH6.0 or EDTA pH8.0
UNSPSC code: 12352203

Prostate-specific antigen (PSA) is a serine protease member of the human glandular kallikrein family. It is synthesized in the prostate ductal and acinar epithelium and diffused into serum. It is found in normal, hyperplastic, and malignant prostate tissue. Low expression of PSA has been reported in other normal or tumor tissues such as urethral, periurethral, and perianal glands, salivary duct carcinoma, and rare mammary carcinomas. Although low PSA expression has been found in other tissues, PSA is still a specific and sensitive marker for immunohistochemical analysis of tumors with prostate epithelial cell differentiation. It is valuable in the identification of metastatic tumors of prostatic origin. (Shipping Cost: €200.00)

PSA (Prostate Specific Antigen) [A67-B/E3]

Prostate-specific antigen (PSA) is a serine protease member of the human glandular kallikrein family. It is synthesized in the prostate ductal and acinar epithelium and diffused into serum. It is found in normal, hyperplastic, and malignant prostate tissue. Low expression of PSA has been reported in other normal or tumor tissues such as urethral, periurethral, and perianal glands, salivary duct carcinoma, and rare mammary carcinomas. Although low PSA expression has been found in other tissues, PSA is still a specific and sensitive marker for immunohistochemical analysis of tumors with prostate epithelial cell differentiation. It is valuable in the identification of metastatic tumors of prostatic origin.